Kaay, D.C.M. van der

level treatment children growth igfbp gnrha treatment igfbp -3 levels gnrha hormone igf-i gh levels 3 months sga children height study profile endocrinol gh treatment puberty group chapter pubertal adult prepubertal insulin metab month baseline factor gnrh agonist test growth hormone stage growth hormone treatment result adult height insulin sensitivity effect insulin-like gh dosage groups subject promoter protein igfbp -3 sds response secretion agonist haplotype serum binding control stature increase sga girls methylation body composition 1 year sga subjects netherland fsh levels -202/c fsh profiles igf-i levels pubertal suppression gh profiles birth -202 sensitivity height sds 3 iu /l clin endocrinol peak lhgnrh genotype tanner gnrh analogue percentage sga adults population change year growth response muinck keizer-schrama sm